ReviewTherapeutic advances in medical oncology2018

Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy.

Tiziana Vavalà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.